ArticleTherapeutic advances in neurological disorders2018

Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN.

Scott D Newsome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.